Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSecure Trust Bank Regulatory News (STB)

Share Price Information for Secure Trust Bank (STB)

Share Price is delayed by 15 minutes
Get Live Data
1,276.00    6.00 (0.47%)
Bid:
1,280.00
Ask:
1,306.00
Spread: 26.00 (2.031%)
Market Cap: £239.05m
STB Live PriceLast checked at - London Stock Exchange

Intraday Secure Trust Bank Share Chart

Pre-Close Statement

10 Jan 2012 07:01

RNS Number : 2559V
Arbuthnot Banking Group PLC
10 January 2012
 



 

For Immediate Release

 

PRESS RELEASE 10 January 2012

 

 

 

 ARBUTHNOT BANKING GROUP PLC

 

 

PRE-CLOSE STATEMENT

 

 

Overall 2011 has been a successful year for Arbuthnot Banking Group PLC ("ABG" or the "Group"). The economic and business environment remained difficult in 2011 but ABG has taken some major steps, creating significant value for shareholders and positioning the Group to enable it to take advantage of the opportunities that are currently available.

 

The two most important events during the year were the IPO of Secure Trust Bank PLC ("STB") and the sale of Arbuthnot Securities Limited ("ASL").

 

The Group's capital position has been further strengthened by the IPO of STB. Arbuthnot Latham and STB remain highly liquid and both banks are continuing to grow their balance sheet and fee income.

 

The sale of ASL requires regulatory approval before it can be completed and this was not received before the year end. The results will therefore, include approximately £8 million trading losses for the year and £3.5 million of provisions in respect of the costs of an employee share scheme but will exclude the final loss on sale which is expected to be approximately £1 million. ASL's results for the year will be reported as discontinued operations.

 

STB continues to work on significant organic and external business opportunities. However, in respect of the consumer finance joint venture previously mentioned by ABG, despite exhaustive efforts we have been unable to agree a structure which meets the regulatory requirements and falls within our risk appetite; consequently the joint venture will not be proceeding as expected. As a result anticipated income associated with the joint venture has not been received and some extra costs associated with carrying excess deposits have been incurred. 

 

Accordingly, ABG expects profits before tax in 2011 for the continuing operations to be around £5.0 million. In addition ABG expects to record in its profit and loss reserves a gain on the sale of the shares in STB of approximately £16.5 million.

 

STB is also making a pre close statement today which should be read in conjunction with this statement.

 

Enquiries:

 

Arbuthnot Banking Group PLC Tel: 020 7012 2400

Henry Angest, Chairman and Chief Executive

Andrew Salmon, Chief Operating Officer

James Cobb, Group Finance Director

David Marshall, Director of Communications

 

Hawkpoint Partners Limited (Nominated Adviser) Tel: 020 7665 4500

Lawrence Guthrie

 

Numis Securities Limited Tel: 020 7260 1000

Christopher Wilkinson

Mark Lander

 

Pelham Bell Pottinger Tel: 020 7861 3232

Ben Woodford

Dan de Belder

 

 

Notes to editors:

Arbuthnot Banking Group consists of three main subsidiaries providing banking services to a wide cross-section of clients.

 

Arbuthnot Latham is the private banking and wealth management arm of the group. It provides banking, financial planning and investment management services to clients.

 

The group also has a full-service, integrated investment bank, Arbuthnot Securities, which offers a full range of institutional stockbroking and corporate advisory services and is focused on UK growth companies.

 

The retail banking arm of the group is Secure Trust Bank. Secure Trust Bank provides a wide scope of services to customers including personal loans, current and savings accounts and financial advice.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBIGDBIGGBGDC
Date   Source Headline
17th Aug 20232:10 pmRNSDirector/PDMR Shareholding
10th Aug 202310:54 amRNSDirector/PDMR Shareholding
10th Aug 20237:00 amRNSDirector/PDMR Shareholding
3rd Aug 20232:25 pmRNSHolding(s) in Company
1st Aug 20235:23 pmRNSTotal Voting Rights
14th Jul 20232:33 pmRNSIssue of Equity
3rd Jul 20232:04 pmRNSBlock listing Interim Review
3rd Jul 20232:02 pmRNSTotal Voting Rights
3rd Jul 20231:59 pmRNSChange of Registered Office
23rd Jun 20235:00 pmRNSIssue of Equity
16th Jun 202311:39 amRNSDirector/PDMR Shareholding
1st Jun 202311:20 amRNSTotal Voting Rights
18th May 20234:34 pmRNSResult of AGM
18th May 20237:00 amRNSQ1 2023 Trading Update
17th May 20235:29 pmRNSIssue of Equity
3rd May 20233:26 pmRNSTotal Voting Rights
27th Apr 20231:50 pmRNSIssue of Equity
13th Apr 20234:13 pmRNSIssue of Equity
11th Apr 20234:46 pmRNSAnnual Report and Accounts and Notice of AGM
4th Apr 20233:19 pmRNSTotal Voting Rights
31st Mar 20232:00 pmRNSDirector/PDMR Shareholding
31st Mar 20232:00 pmRNSDirector/PDMR Shareholding
30th Mar 20237:01 amRNSChairman to retire AGM 2024
30th Mar 20237:00 amRNSSecure Trust Bank Annual Results to End of 2022
17th Mar 20235:03 pmRNSTotal Voting Rights
17th Mar 20231:58 pmRNSBuyback of Tier 2 Bonds
14th Mar 20233:37 pmRNSIssue of Equity
9th Mar 20234:34 pmRNSHolding(s) in Company
1st Mar 20232:23 pmRNSTotal Voting Rights
27th Feb 202310:28 amRNSPublication of Admission Particulars
22nd Feb 20236:20 pmRNSNew Tier 2 Issue Pricing and Buyback of securities
16th Feb 20233:26 pmRNSIssue of Equity
9th Feb 20234:54 pmRNSHolding(s) in Company
2nd Feb 20237:00 amRNSIssue of Equity
19th Jan 20237:00 amRNSPre Close Trading Update
9th Jan 20234:39 pmRNSBlock listing Interim Review
4th Jan 20234:35 pmRNSPrice Monitoring Extension
4th Jan 202311:22 amRNSAdditional Listing
3rd Jan 202311:30 amRNSTotal Voting Rights
1st Dec 202212:13 pmRNSTotal Voting Rights
15th Nov 202210:42 amRNSIssue of Equity
9th Nov 20224:28 pmRNSIssue of Equity
9th Nov 20223:53 pmRNSPurchase of shares by Employee Benefit Trust
28th Oct 20222:50 pmRNSChange of Directors' Details
27th Oct 20227:00 amRNSQ3 2022 Trading Update
21st Sep 20225:35 pmRNSDirector/PDMR Shareholding
21st Sep 20227:00 amRNSDirectorate Change
15th Sep 20229:57 amRNSHolding(s) in Company
8th Sep 20224:04 pmRNSHolding(s) in Company
5th Sep 20221:03 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.